List of Excipients in API GLIPIZIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GLIPIZIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Roerig | GLUCOTROL | glipizide | 0049-0170 | CELLULOSE ACETATE | |
| Roerig | GLUCOTROL | glipizide | 0049-0170 | FERRIC OXIDE RED | |
| Roerig | GLUCOTROL | glipizide | 0049-0170 | HYPROMELLOSE | |
| Roerig | GLUCOTROL | glipizide | 0049-0170 | MAGNESIUM STEARATE | |
| Roerig | GLUCOTROL | glipizide | 0049-0170 | POLYETHYLENE GLYCOL | |
| Roerig | GLUCOTROL | glipizide | 0049-0170 | SODIUM CHLORIDE | |
| Roerig | GLUCOTROL | glipizide | 0049-1620 | CELLULOSE ACETATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing GLIPIZIDE
Detailed excipient profiles for GLIPIZIDE
Excipient focus: ACETYLTRIBUTYL CITRATE
GLIPIZIDE drug variants containing ACETYLTRIBUTYL CITRATE
GLIPIZIDE drug variants not containing ACETYLTRIBUTYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
GLIPIZIDE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | glipizide | 60687-768 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
GLIPIZIDE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | glipizide | 16714-894 |
| Zydus Pharmaceuticals USA Inc | glipizide | 68382-335 |
| REMEDYREPACK INC | glipizide | 70518-3645 |
| Zydus Lifesciences Limited | glipizide | 70771-1098 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
GLIPIZIDE drug variants containing AMMONIA
GLIPIZIDE drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
GLIPIZIDE drug variants containing ANHYDROUS LACTOSE
GLIPIZIDE drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| Northstar Rx LLC | glipizide | 16714-894 |
| Rebel Distributors Corp | glipizide | 21695-967 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
GLIPIZIDE drug variants containing BUTYL ALCOHOL
GLIPIZIDE drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
GLIPIZIDE drug variants containing BUTYLATED HYDROXYTOLUENE
GLIPIZIDE drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
GLIPIZIDE drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Par Pharmaceutical Inc | glipizide | 10370-745 |
| A-S Medication Solutions | glipizide | 50090-2915 |
| A-S Medication Solutions | glipizide | 50090-3069 |
| A-S Medication Solutions | glipizide | 50090-5040 |
| A-S Medication Solutions | glipizide | 50090-5806 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
GLIPIZIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
GLIPIZIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETEARETH-8
GLIPIZIDE drug variants containing CETEARETH-8
GLIPIZIDE drug variants not containing CETEARETH-8
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
GLIPIZIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal, Inc. | glipizide | 10544-193 |
| STAT Rx USA LLC | glipizide | 16590-286 |
| Rebel Distributors Corp | glipizide | 21695-469 |
| H.J. Harkins Company, Inc. | glipizide | 52959-822 |
| Physicians Total Care, Inc. | glipizide | 54868-3318 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
GLIPIZIDE drug variants containing CROSCARMELLOSE SODIUM
GLIPIZIDE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
GLIPIZIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | glipizide | 64980-279 |
| Preferred Pharmaceuticals Inc | glipizide | 68788-8487 |
| REMEDYREPACK INC | glipizide | 70518-2308 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
GLIPIZIDE drug variants containing FD&C RED NO. 40
GLIPIZIDE drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
GLIPIZIDE drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | glipizide | 16714-894 |
| NuCare PharmaceuticalsInc | glipizide | 68071-4994 |
| Zydus Pharmaceuticals USA Inc | glipizide | 68382-335 |
| REMEDYREPACK INC | glipizide | 70518-3645 |
| Zydus Lifesciences Limited | glipizide | 70771-1098 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
GLIPIZIDE drug variants containing FD&C YELLOW NO. 6
GLIPIZIDE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
GLIPIZIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| A-S Medication Solutions | glipizide | 50090-5040 |
| A-S Medication Solutions | glipizide | 50090-5806 |
| Northwind Pharmaceuticals LLC | glipizide | 51655-337 |
| Northwind Pharmaceuticals LLC | glipizide | 51655-361 |
| Northwind Pharmaceuticals LLC | glipizide | 51655-966 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
GLIPIZIDE drug variants containing FERRIC OXIDE YELLOW
GLIPIZIDE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
GLIPIZIDE drug variants containing FERROSOFERRIC OXIDE
GLIPIZIDE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
GLIPIZIDE drug variants containing GLYCERYL MONOSTEARATE
GLIPIZIDE drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
GLIPIZIDE drug variants containing HYDROXYETHYL CELLULOSE
GLIPIZIDE drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
GLIPIZIDE drug variants containing HYDROXYPROPYL CELLULOSE
GLIPIZIDE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
GLIPIZIDE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| A-S Medication Solutions | glipizide | 50090-2915 |
| A-S Medication Solutions | glipizide | 50090-3069 |
| A-S Medication Solutions | glipizide | 50090-5377 |
| A-S Medication Solutions | glipizide | 50090-6848 |
| A-S Medication Solutions | glipizide | 50090-6849 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
GLIPIZIDE drug variants containing HYPROMELLOSE 2910
GLIPIZIDE drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
GLIPIZIDE drug variants containing HYPROMELLOSES
GLIPIZIDE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
GLIPIZIDE drug variants containing ISOPROPYL ALCOHOL
GLIPIZIDE drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
GLIPIZIDE drug variants containing LACTOSE
GLIPIZIDE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
GLIPIZIDE drug variants containing LACTOSE MONOHYDRATE
GLIPIZIDE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
GLIPIZIDE drug variants containing MAGNESIUM STEARATE
GLIPIZIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
GLIPIZIDE drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | glipizide | 53808-0401 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
GLIPIZIDE drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
GLIPIZIDE drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
GLIPIZIDE drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | glipizide | 68788-4061 |
| Oxford Pharmaceuticals LLC | glipizide | 69584-309 |
| Proficient Rx LP | glipizide | 82804-959 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
GLIPIZIDE drug variants containing MICROCRYSTALLINE CELLULOSE 102
GLIPIZIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: PALMITOSTEARIC ACID
GLIPIZIDE drug variants containing PALMITOSTEARIC ACID
GLIPIZIDE drug variants not containing PALMITOSTEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Par Pharmaceutical Inc | glipizide | 10370-745 |
| Northstar Rx LLC | glipizide | 16714-894 |
| Rebel Distributors Corp | glipizide | 21695-967 |
| A-S Medication Solutions | glipizide | 50090-2220 |
| A-S Medication Solutions | glipizide | 50090-2915 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL 3350
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL 400
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | glipizide and metformin hydrochloride | 0093-7455 |
| REMEDYREPACK INC | glipizide and metformin hydrochloride | 70518-0373 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL 6000
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 7000000
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOL 7000000
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOL 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
GLIPIZIDE drug variants containing POLYETHYLENE GLYCOLS
GLIPIZIDE drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 200000
GLIPIZIDE drug variants containing POLYETHYLENE OXIDE 200000
GLIPIZIDE drug variants not containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 7000000
GLIPIZIDE drug variants containing POLYETHYLENE OXIDE 7000000
GLIPIZIDE drug variants not containing POLYETHYLENE OXIDE 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
GLIPIZIDE drug variants containing POLYSORBATE 80
GLIPIZIDE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
GLIPIZIDE drug variants containing POLYVINYL ALCOHOL
GLIPIZIDE drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
GLIPIZIDE drug variants containing POVIDONE
GLIPIZIDE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
GLIPIZIDE drug variants containing POVIDONE K30
GLIPIZIDE drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
GLIPIZIDE drug variants containing POVIDONE K90
GLIPIZIDE drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
GLIPIZIDE drug variants containing PROPYLENE GLYCOL
GLIPIZIDE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: SAND
GLIPIZIDE drug variants containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glipizide | 50090-0502 |
| A-S Medication Solutions | glipizide | 50090-0505 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
GLIPIZIDE drug variants containing SHELLAC
GLIPIZIDE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA
GLIPIZIDE drug variants containing SILICA
GLIPIZIDE drug variants not containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
GLIPIZIDE drug variants containing SILICON DIOXIDE
GLIPIZIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| Blenheim Pharmacal, Inc. | glipizide | 10544-193 |
| STAT Rx USA LLC | glipizide | 16590-286 |
| Rebel Distributors Corp | glipizide | 21695-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
GLIPIZIDE drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Par Pharmaceutical Inc | glipizide | 10370-745 |
| A-S Medication Solutions | glipizide | 50090-2915 |
| A-S Medication Solutions | glipizide | 50090-3069 |
| A-S Medication Solutions | glipizide | 50090-5040 |
| A-S Medication Solutions | glipizide | 50090-5806 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
GLIPIZIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
GLIPIZIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
GLIPIZIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
GLIPIZIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
GLIPIZIDE drug variants containing STARCH, CORN
GLIPIZIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-5585 |
| NCS HealthCare of KY LLC dba Vangard Labs | glipizide | 0615-7968 |
| Major Pharmaceuticals | glipizide | 0904-6637 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, POTATO
GLIPIZIDE drug variants containing STARCH, POTATO
GLIPIZIDE drug variants not containing STARCH, POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
GLIPIZIDE drug variants containing STEARIC ACID
GLIPIZIDE drug variants not containing STEARIC ACID
Excipient focus: TALC
GLIPIZIDE drug variants containing TALC
GLIPIZIDE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
GLIPIZIDE drug variants containing TITANIUM DIOXIDE
GLIPIZIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
GLIPIZIDE drug variants containing TRIACETIN
GLIPIZIDE drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZEA MAYS
GLIPIZIDE drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glipizide | 50090-6473 |
| >Company | >Ingredient | >NDC |
GLIPIZIDE drug variants not containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | glipizide | 0049-0170 |
| Roerig | glipizide | 0049-1620 |
| Roerig | glipizide | 0049-4110 |
| Mylan Pharmaceuticals Inc | glipizide | 0378-1105 |
| Actavis Pharma, Inc. | glipizide | 0591-0460 |
| Actavis Pharma Inc | glipizide | 0591-0844 |
| NCS HealthCare of KY Inc dba Vangard Labs | glipizide | 0615-3595 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
